Investigators reported that the splicing factor SRSF1 was highly expressed in pancreatitis, pancreatic ductal adenocarcinoma (PDAC) precursor lesions, and tumors. Increased SRSF1 was sufficient to induce pancreatitis and accelerate KRASG12D-mediated PDAC.
[Cancer Discovery]